Yıl: 2021 Cilt: 17 Sayı: 3 Sayfa Aralığı: 274 - 282 Metin Dili: İngilizce DOI: 10.4274/ejbh.galenos.2021.6255 İndeks Tarihi: 12-11-2021

Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer

Öz:
Objective: Liposomal cancer treatment strategies are useful in removing the side effects that were the main concern in recent years. In this study, we prepared microbubble (MBs) conjugated with DOX-loaded liposomes (DOX-loaded MBs) and investigated their effectiveness in in vitro breast cancer cells in two dimensions (2D) and three dimensions (3D).Materials and Methods: With this aim, breast cancer cells with different features (4T1, MDA-MB231, MCF-7) were growth in 2D and 3D dimensions. The cytotoxic and cell death effects under different conditions, durations and doses were evaluated with WST-1, trypan-blue, colony counts. Apoptotic effects were investigated with flow cytometric Annexin-V-PI and immunohistochemical (Ki-67, caspase 3, 8, 9) methods.Results: After free DOX and LipoDOX were applied, the proliferation index of three cell lines reduced. Intrinsic and extrinsic apoptotic pathways were activated in both 2D and 3D models. However, this effect was observed at lower levels in the 3D model due to the difficulty of diffusion of DOX into the spheroids. Additionally, the suitability of the 3D model for breast cancer cells was supported by formation of ductus-like structures and spheroids. Cell deaths were not observed significantly with the DOX-loaded microbubbles due to rising of MBs to the surface and not reaching spheroids held in matrigel of 3D model.Conclusion: DOX and LipoDOX showed anti-proliferative and apoptosis-inducing effects in breast cancer cells. However, these effects indicated variability depending on the cell lines and 2D or 3D model types.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
0
0
0
  • 1. Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin 2018; 68: 488-505. (PMID: 30328620) [Crossref]
  • 2. Narod SA. Personalised medicine and population health: breast and ovarian cancer. Hum Genet 2018; 137: 769-778. (PMID: 30328515) [Crossref]
  • 3. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004; 117: 1495-1502. (PMID: 14996910) [Crossref]
  • 4. Smalley M, Piggott L, Clarkson R. Breast cancer stem cells: obstacles to therapy. Cancer Lett 2013; 338: 57-62. (PMID: 22554712) [Crossref]
  • 5. Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 2011; 414: 161-170. (PMID: 21609756) [Crossref]
  • 6. Yan F, Li L, Deng Z, Jin Q, Chen J, Yang W, et al. Paclitaxel-liposomemicrobubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release 2013; 166: 246-255. (PMID: 23306023) [Crossref]
  • 7. Vail DM, Amantea MA, Colbern GT, Martin FJ, Hilger RA, Working PK. Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin Oncol 2004; 31: 16- 35. (PMID: 15717736) [Crossref]
  • 8. Harris L, Batist G, Belt R, Rovira D, Navari R, Azarnia N, et al. Liposomeencapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma. Cancer 2002: 94: 25-36. (PMID: 11815957) [Crossref]
  • 9. Bush N, Healey A, Shah A, Box G, Kirkin V, Eccles S, et al. Theranostic attributes of acoustic cluster therapy and its use for enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice. Front Pharmacol 2020; 11: 75. (PMID: 32153400) [Crossref]
  • 10. Pothuri B, Brodsky AL, Sparano JA, Blank SV, Kim M, Hershman DL, et al. Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up. Cancer Chemother Pharmacol 2020; 85: 741-751. (PMID: 32055930) [Crossref]
  • 11. Zhao T, Zhou H, Lei L, Guo C, Yang Q, Gong T, et al. A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy". Nanoscale 2020; 12: 3359-3369. (PMID: 31984408) [Crossref]
  • 12. Navashenaq JG, Zamani P, Nikpoor AR, Tavakkol-Afshari J, Jaafari MR. Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer. Nanomedicine 2020; 24: 102150. doi: 10.1016/j.nano.2020.102150 (PMID: 31931230) [Crossref]
  • 13. Cao D, Zhang X, Akabar MD, Luo Y, Wu H, Ke X, et al. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer. Artif Cells Nanomed Biotechnol 2019; 47: 181-191. (PMID: 30686051) [Crossref]
  • 14. Lin CY, Li JR, Tseng HC. Enhancement of focused ultrasound with microbubbles on the treatments of anticancer nanodrug in mouse tumors. Nanomedicine 2012; 8: 900-907. (PMID: 22033084) [Crossref]
  • 15. Tinkov S, Coester C, Serba S, Geis NA, Katus HA, Winter G, et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release 2010; 148: 368-372. (PMID: 20868711) [Crossref]
  • 16. Onercan C. Development of ultrasound triggered drug delivery systems for cancer treatment. Izmir Institute of Technology, Master Thesis, Turkey, 2019. [Crossref]
  • 17. Weigelt B, Ghajar CM, Bissell MJ. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev 2014; 69-70: 42-51. (PMID: 24412474) [Crossref]
  • 18. Imamura Y, Mukohara T, Shimono Y, Funakoshi Y, Chayahara N, Toyoda M, et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep 2015; 33: 1837-1843. (PMID: 25634491) [Crossref]
  • 19. Lee JM, Mhawech-Fauceglia P, Lee N, Parsanian LC, Lin YG, Gayther SA, et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest 2013; 93: 528-542. (PMID: 23459371) [Crossref]
  • 20. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 2012; 10: 29. (PMID: 22439642) [Crossref]
APA AYDIN M, Ozdemir E, ALTUN Z, KILIÇ S, Aktas S (2021). Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. , 274 - 282. 10.4274/ejbh.galenos.2021.6255
Chicago AYDIN Melek,Ozdemir Ekrem,ALTUN Zekiye,KILIÇ Sevgi,Aktas Safiye Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. (2021): 274 - 282. 10.4274/ejbh.galenos.2021.6255
MLA AYDIN Melek,Ozdemir Ekrem,ALTUN Zekiye,KILIÇ Sevgi,Aktas Safiye Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. , 2021, ss.274 - 282. 10.4274/ejbh.galenos.2021.6255
AMA AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. . 2021; 274 - 282. 10.4274/ejbh.galenos.2021.6255
Vancouver AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. . 2021; 274 - 282. 10.4274/ejbh.galenos.2021.6255
IEEE AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S "Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer." , ss.274 - 282, 2021. 10.4274/ejbh.galenos.2021.6255
ISNAD AYDIN, Melek vd. "Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer". (2021), 274-282. https://doi.org/10.4274/ejbh.galenos.2021.6255
APA AYDIN M, Ozdemir E, ALTUN Z, KILIÇ S, Aktas S (2021). Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. European Journal of Breast Health, 17(3), 274 - 282. 10.4274/ejbh.galenos.2021.6255
Chicago AYDIN Melek,Ozdemir Ekrem,ALTUN Zekiye,KILIÇ Sevgi,Aktas Safiye Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. European Journal of Breast Health 17, no.3 (2021): 274 - 282. 10.4274/ejbh.galenos.2021.6255
MLA AYDIN Melek,Ozdemir Ekrem,ALTUN Zekiye,KILIÇ Sevgi,Aktas Safiye Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. European Journal of Breast Health, vol.17, no.3, 2021, ss.274 - 282. 10.4274/ejbh.galenos.2021.6255
AMA AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. European Journal of Breast Health. 2021; 17(3): 274 - 282. 10.4274/ejbh.galenos.2021.6255
Vancouver AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer. European Journal of Breast Health. 2021; 17(3): 274 - 282. 10.4274/ejbh.galenos.2021.6255
IEEE AYDIN M,Ozdemir E,ALTUN Z,KILIÇ S,Aktas S "Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer." European Journal of Breast Health, 17, ss.274 - 282, 2021. 10.4274/ejbh.galenos.2021.6255
ISNAD AYDIN, Melek vd. "Evaluation of Liposomal and Microbubbles MediatedDelivery of Doxorubicin in Two-Dimensional (2D) andThree-Dimensional (3D) Models for Breast Cancer". European Journal of Breast Health 17/3 (2021), 274-282. https://doi.org/10.4274/ejbh.galenos.2021.6255